GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding

Abstract

Multiple peptide systems, including neuropeptide Y, leptin, ghrelin, and others, are involved with the control of food intake and body weight. The peptide LENSSPQAPARRLLPP (BigLEN) has been proposed to act through an unknown receptor to regulate body weight. In the present study, we used a combination of ligandbinding and receptor-activity assays to characterize a Gα i/o proteincoupled receptor activated by BigLEN in the mouse hypothalamus and Neuro2A cells. We then selected orphan G protein-coupled receptors expressed in the hypothalamus and Neuro2A cells and tested each for activation by BigLEN. G protein-coupled receptor 171 (GPR171) is activated by BigLEN, but not by the C terminally truncated peptide LittleLEN. The four C-terminal amino acids of BigLEN are sufficient to bind and activate GPR171. Overexpression of GPR171 leads to an increase, and knockdown leads to a decrease, in binding and signaling by BigLEN and the C-terminal peptide. In the hypothalamus GPR171 expression complements the expression of BigLEN, and its level and activity are elevated in mice lacking BigLEN. In mice, shRNA-mediated knockdown of hypothalamic GPR171 leads to a decrease in BigLEN signaling and results in changes in food intake and metabolism. The combination of GPR171 shRNA together with neutralization of BigLEN peptide by antibody absorption nearly eliminates acute feeding in food-deprived mice. Taken together, these results demonstrate that GPR171 is the BigLEN receptor and that the BigLEN-GPR171 system plays an important role in regulating responses associated with feeding and metabolism in mice.proSAAS | NPY/AgRP | neuroendocrine peptide | deorphanization | orexigenic

Opioid Receptor Function Is Regulated by Post-endocytic Peptide Processing

“…Cells were incubated with 1 M Delt II or 100 nM BAM22 for 30 min at 37°C in the absence or presence of 10 M forskolin and 100 M IBMX. The cells were washed and incubated without or with 20 M ECE2 inhibitor (S136492), 100 M chloroquine, 10 M captopril, or 100 nM cycloheximide for 60 min, and the levels of cAMP in response to a second pulse (5-min treatment) of Delt II or BAM22 were determined using the HitHunter cAMP HS chemiluminescence detection kit from DiscoveRx (36). This kit measures cAMP in cells using an enzyme fragment complementation technology in which cAMP from cells and cAMP labeled with a ␤-galactosidase fragment compete for binding to an antibody to cAMP.…”

Ghrelin: Ghrelin as a Regulatory Peptide in Growth Hormone Secretion

“…The studies have proposed that ghrelin acts on both the somatotrophs of the anterior pituitary gland and GHRH-secreting neurons and on GHIH-secreting neurons (opposes the action of somatostatin) in the hypothalamus via GHSR 1a, a G protein-coupled receptor [36,37]. Once ghrelin binds with GHSR-1a, it gets activated which further activates phospholipase C (PLC) attached to the inner portions of the receptors .…”

Identification of GPR83 as the receptor for the neuroendocrine peptide PEN

“…GPR171 is present in the hypothalamus and other areas involved in feeding and body weight regulation (13). GPR171 does not bind PEN; therefore, we tested for the existence of a PEN receptor.…”